BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Stent Graft, Bypass, Superficial Femoral Artery

    PMA: P220021 · Supplement: S004 · Decision Mar 3, 2025
    View on FDA
    Classifications
    1
    FEI Numbers
    1
    Registration Numbers
    1

    Basic Information

    Device Name
    Stent Graft, Bypass, Superficial Femoral Artery
    Trade Name
    DETOUR System
    PMA Number
    P220021
    Supplement Number
    S004
    Device Class
    FDA Class 3
    Product Code
    QWM
    Generic Name
    Stent graft, bypass, superficial femoral artery
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    March 3, 2025
    Date Received
    February 7, 2025
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    approval for processing changes to the outer shaft of the stent graft delivery system

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    QWM Stent Graft, Bypass, Superficial Femoral Artery